ClassID:

95365

C07D471/12 - CPC Classification

Classification description:

Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups  -  in which the condensed system contains three hetero rings

Sub-classes:
Recent Application in this class:
#1
20250296932
2025-09-25

PHARMACEUTICAL COMPOSITIONS COMPRISING HIV INTEGRASE INHIBITORS

#2
20250109133
2025-04-03

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[l,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FORTHEIR USE IN THERAPY

#3
20240300948
2024-09-12

Heterocyclic Compounds As Kinase Inhibitors

#4
20240279258
2024-08-22

MODULATORS OF TNF-ALPHA ACTIVITY

#5
20240270746
2024-08-15

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZ0[1,2-A]PYRID0[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY

#6
20220119389
2022-04-21

Berbamine derivatives and methods of use thereof

#7
20220104496
2022-04-07

PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS

#8
20220017519
2022-01-20

7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy

#9
20210037827
2021-02-11

Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents

#10
20200147135
2020-05-14

Compositions and methods for an improved antitumor immune response

#11
20200131200
2020-04-30

Spiroheptane salicylamides and related compounds as inhibitors of ROCK

#12
20200024418
2020-01-23

Reversibly cross-linkable resin

#13
20190210972
2019-07-11

Methods of resolving racemic mixture to obtain (−)-Huperzine A

#14
20190194201
2019-06-27

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY

#15
20190169197
2019-06-06

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#16
20180312530
2018-11-01

PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES

#17
20180162859
2018-06-14

TETRACYCLIC AUTOTAXIN INHIBITORS

#18
20180114923
2018-04-26

Heterocyclic compound and organic light emitting element comprising same

#19
20180099982
2018-04-12

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#20
20180072729
2018-03-15

7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy

#21
20180044495
2018-02-15

Reversibly cross-linkable resin

#22
20170355703
2017-12-14

Compounds for the inhibition of indoleamine-2,3-dioxygenase

#23
20170334920
2017-11-23

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#24
20170022205
2017-01-26

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#25
20160264575
2016-09-15

Tetracyclic autotaxin inhibitors

#26
20160255837
2016-09-08

Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents

#27
20160096808
2016-04-07

Methods of resolving racemic mixture to obtain (−)-huperzine A

#28
20160075711
2016-03-17

Compounds for the inhibition of indoleamine-2,3-dioxygenase

#29
20160031884
2016-02-04

Tetrahydrocarboline derivative

#30
20150368422
2015-12-24

Reversibly cross-linkable resin

#31
20150361099
2015-12-17

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#32
20150299132
2015-10-22

Aromatic imide compound and method for producing same

#33
20150119392
2015-04-30

RAF inhibitor compounds

#34
20140364443
2014-12-11

1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof

#35
20140256710
2014-09-11

Bromodomain inhibitors

#36
20140142309
2014-05-22

Process for the preparation of tadalafil

#37
20140100237
2014-04-10

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#38
20120322816
2012-12-20

Rutaecarpine derivatives for activating CYP1A2 in a subject

#39
20120277216
2012-11-01

1,2-dihydro-2-oxoquinoline compounds as 5-HTreceptor ligands

#40
20120245291
2012-09-27

Polytriazinyl Compounds as Flame Retardants and Light Stabilizers

#41
20120071594
2012-03-22

Polytriazinyl compounds as flame retardants and light stabilizers

#42
20110319433
2011-12-29

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#43
20110237596
2011-09-29

Heteroaryl-substituted urea modulators of fatty acid amide hydrolase

#44
20110237571
2011-09-29

Phthalazine derivatives as inhibitors of protein kinase

#45
20110184176
2011-07-28

Producing method of nitrogen containing condensed heterocyclic compound

#46
20100228030
2010-09-09

Process for the preparation of an intermediate of tadalafil

#47
20100190816
2010-07-29

Kinase inhibitors

#48
20100036122
2010-02-11

CLEAVAGE AGENT SELECTIVELY ACTING ON SOLUBLE ASSEMBLY OF AMYLOIDOGENIC PEPTIDE OR PROTEIN

#49
20090281215
2009-11-12

Polytriazinyl Compounds as Flame Retardants and Light Stabilizers

#50
20090233946
2009-09-17

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

#51
20090170832
2009-07-02

Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity

#52
20080249309
2008-10-09

Organic semiconductor materials and precursors thereof

#53
20080221154
2008-09-11

HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE

#54
20080146547
2008-06-19

Phthalazine derivatives as inhibitors of protein kinase

#55
20070219196
2007-09-20

Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines

#56
20070203133
2007-08-30

Substituted 5,12-diaza-benzoanthracene analogues

#57
20070117816
2007-05-24

Kinase inhibitors

#58
20070004768
2007-01-04

HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use